Jiehan Li
1 East Jianshe Road
Zhengzhou, China
Zhengzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
GALNT7 promotes the malignant progression of gastrointestinal stromal tumors by regulating KIT O-GalNAc glycosylation.
Journal: Precision clinical medicine
Published: March 17, 2026
Targeting tumor dormancy: the next frontier in gastrointestinal stromal tumor therapy.
Journal: Neoplasia (New York, N.Y.)
Published: February 26, 2026
Dual-faced PUMA in CRC: A cytoplasmic autophagy repressor and mitochondrial mitophagy promoter.
Journal: Cellular signalling
Published: October 11, 2025
WITHDRAWN: Multi-omics integration deciphers immune-metabolic heterogeneity in CRC: A prognostic model and therapeutic strategies targeting ANGPTL4/FABP4/RBP7.
Journal: Computers in biology and medicine
Published: July 01, 2025
SIRT6-Mediated Regulation of TFAM: A Central Mechanism Connecting Nuclear and Mitochondrial Transcriptional Processes and Mitophagy.
Journal: International journal of biological sciences
Published: June 20, 2025
Unraveling the miR-144-3p/PUMA pathway: a novel regulator of FDX1-mediated cuproptosis in colorectal cancer.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: April 16, 2025
Immunogenic cuproptosis in cancer immunotherapy via an in situ cuproptosis-inducing system.
Journal: Biomaterials
Published: December 14, 2024
A machine learning model integrating clinical-radiomics-deep learning features accurately predicts postoperative recurrence and metastasis of primary gastrointestinal stromal tumors.
Journal: Insights into imaging
Published: December 01, 2024
Exosome miR-199a-5p modulated vascular remodeling and inflammatory infiltration of Takayasu's arteritis.
Journal: Arthritis research & therapy
Published: July 07, 2024
LncRNA CARMN m6A demethylation by ALKBH5 inhibits mutant p53-driven tumour progression through miR-5683/FGF2.
Journal: Clinical and translational medicine
Published: February 05, 2024
Targeting AKT induced Ferroptosis through FTO/YTHDF2-dependent GPX4 m6A methylation up-regulating and degradating in colorectal cancer.
Journal: Cell death discovery
Published: March 30, 2023
Inhibition of AKT induces p53/SIRT6/PARP1-dependent parthanatos to suppress tumor growth.
Journal: Cell communication and signaling : CCS
Published: January 09, 2022
Last Updated: 09/26/2026